Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EVMNEvommune, Inc.

NYSE · CIK 0002044725
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts223

Identity from submissions API

NameEvommune, Inc.
CIK0002044725
TickersEVMN
ExchangesNYSE
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN850742575
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(650) 223-7745
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1891 PAGE MILL RD
PALO ALTO
CA
CA
Mailing address
1891 PAGE MILL RD
PALO ALTO
CA
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

155 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 PRIMARY DOCUMENT 0001290976-26-000006 13908
2026-11-17 4 PRIMARY DOCUMENT 0001347383-26-000005 13761
2026-11-17 4 PRIMARY DOCUMENT 0001216994-26-000005 13777
2026-11-17 4 PRIMARY DOCUMENT 0002091053-26-000007 14088
2026-11-17 4 PRIMARY DOCUMENT 0002092017-26-000009 14100
2026-11-17 4 PRIMARY DOCUMENT 0001757072-26-000009 14062
2026-11-17 4 PRIMARY DOCUMENT 0001742496-26-000007 14080
2026-11-17 4 PRIMARY DOCUMENT 0001678620-26-000005 14076
2026-11-17 4 PRIMARY DOCUMENT 0001620548-26-000011 14097
2026-11-17 424B3 424B3 0001193125-26-465623 333-295140 261566765 33 101777
2026-11-17 8-K 8-K 5.02 0001193125-26-465600 001-42938 261566585 34 181601 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-008112 005-95351 261560842 34 12210
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000727 005-95351 261556472 34 7638
2026-11-12 424B3 424B3 0001193125-26-458509 333-295140 261547397 33 2089878
2026-11-12 10-Q 10-Q 0001193125-26-458385 001-42938 261547034 34 10474626 1 1
2026-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-458329 001-42938 261546865 34 31667976 1 1
2026-11-10 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001346824-26-000259 005-95351 261541198 34 15319
2026-11-05 8-K 8-K 7.01,9.01 0001193125-26-448443 001-42938 261524591 34 1067165 1 1
2026-11-04 424B3 424B3 0001193125-26-447627 333-295140 261523757 33 123696
2026-11-04 8-K 8-K 1.01,3.02,7.01,8.01 0001193125-26-447608 001-42938 261523690 34 12676235 1 1
2026-10-15 4 PRIMARY DOCUMENT 0001620548-26-000009 5280
2026-10-01 8-K 8-K 7.01,9.01 0001193125-26-409865 001-42938 261428981 34 1090597 1 1
2026-09-23 8-K 8-K 7.01,9.01 0001193125-26-399378 001-42938 261401082 34 1080128 1 1
2026-09-15 8-K 8-K 7.01,9.01 0001193125-26-391390 001-42938 261379194 34 18754768 1 1
2026-09-09 424B3 424B3 0001193125-26-385431 333-295140 261366119 33 95868
2026-09-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-385430 001-42938 261366114 34 1083320 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001757283-26-000018 005-95351 261282054 34 13001
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000581 005-95351 261277457 34 7434
2026-08-06 424B3 424B3 0001193125-26-338017 333-295140 261249091 33 2044835
2026-08-06 10-Q 10-Q 0001193125-26-337984 001-42938 261249022 34 9987548 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-337964 001-42938 261248893 34 1256405 1 1
2026-07-30 8-K 8-K 7.01,9.01 0001193125-26-324972 001-42938 261220280 34 1079507 1 1
2026-07-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004453 005-95351 261181089 34 17194
2026-07-10 4 PRIMARY DOCUMENT 0001757072-26-000007 5250
2026-07-08 4 PRIMARY DOCUMENT 0001290976-26-000004 5804
2026-06-29 424B3 424B3 0001193125-26-286924 333-295140 261131472 33 93010
2026-06-29 8-K 8-K 7.01,8.01,9.01 0001193125-26-286918 001-42938 261131468 34 1082840 1 1
2026-06-24 4 PRIMARY DOCUMENT 0002091053-26-000005 13238
2026-06-24 4 PRIMARY DOCUMENT 0002092017-26-000007 9009
2026-06-24 4 PRIMARY DOCUMENT 0001620548-26-000007 5466
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006381 001-42938 261107732 33 4872
2026-06-03 4 PRIMARY DOCUMENT 0001216994-26-000003 5667
2026-06-03 4 PRIMARY DOCUMENT 0001290976-26-000002 5798
2026-06-03 4 PRIMARY DOCUMENT 0001347383-26-000003 9916
2026-06-03 4 PRIMARY DOCUMENT 0002092017-26-000005 9543
2026-06-03 4 PRIMARY DOCUMENT 0001620548-26-000005 5467
2026-06-02 144 xsl144X01/primary_doc.xml 0001950047-26-005513 001-42938 261056805 33 5381
2026-06-02 424B3 424B3 0001193125-26-253489 333-295140 261056010 33 94684
2026-06-02 8-K 8-K 5.07 0001193125-26-253482 001-42938 261055977 34 173019 1 1
2026-06-01 4 PRIMARY DOCUMENT 0001742496-26-000005 10513
2026-06-01 4 PRIMARY DOCUMENT 0001757072-26-000005 9505
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005432 001-42938 261051845 33 5323
2026-06-01 144 xsl144X01/primary_doc.xml 0001950047-26-005430 001-42938 261051835 33 5480
2026-05-28 144 xsl144X01/primary_doc.xml 0001950047-26-005228 001-42938 261036885 33 4635
2026-05-28 144 xsl144X01/primary_doc.xml 0001950047-26-005227 001-42938 261036881 33 5442
2026-05-07 424B3 424B3 0001193125-26-212038 333-295140 26953697 33 1590588
2026-05-07 10-Q 10-Q 0001193125-26-211963 001-42938 26953598 34 8876425 1 1
2026-05-07 8-K 8-K 2.02,7.01 0001193125-26-211934 001-42938 26953432 34 29207448 1 1
2026-04-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001330 333-295140 26896317 33 1659
2026-04-24 424B3 424B3 0001193125-26-177356 333-295140 26894476 33 756996
2026-04-22 CORRESP filename1.htm 0001193125-26-170867 7028
2026-04-22 UPLOAD filename1.pdf 0000000000-26-004089 333-295140 147868
2026-04-21 ARS ARS 0001193125-26-166761 001-42938 26879460 34 5004533
2026-04-21 DEFA14A DEFA14A 0001193125-26-166755 001-42938 26879447 34 2101701 1 1
2026-04-21 DEF 14A DEF 14A 0001193125-26-166747 001-42938 26879421 34 2736630 1 1
2026-04-17 4 PRIMARY DOCUMENT 0002092017-26-000003 5764
2026-04-17 4 PRIMARY DOCUMENT 0002091053-26-000003 5752
2026-04-17 4 PRIMARY DOCUMENT 0001678620-26-000003 5760
2026-04-17 4 PRIMARY DOCUMENT 0001757072-26-000003 5726
2026-04-17 4 PRIMARY DOCUMENT 0001742496-26-000003 5742
2026-04-17 4 PRIMARY DOCUMENT 0001620548-26-000003 5759
2026-04-17 S-1 S-1 0001193125-26-161516 333-295140 26871545 33 1007041 1 1
2026-04-13 8-K 8-K 7.01,9.01 0001193125-26-152864 001-42938 26857899 34 16316788 1 1
2026-03-05 S-8 S-8 0001193125-26-093978 333-294045 26726292 33 645087 1 1
2026-03-05 10-K 10-K 0001193125-26-093932 001-42938 26726149 34 27174798 1 1
2026-03-05 8-K 8-K 2.02 0001193125-26-093920 001-42938 26726104 34 23518496 1 1
2026-02-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-059504 005-95351 26654903 34 12592
2026-02-19 4 4 0001193125-26-059500 5691
2026-02-18 4 xslF345X05/form4-02192026_020236.xml 0002094941-26-000002 5103
2026-02-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-26-000063 005-95351 26644619 34 17689
2026-02-17 4 xslF345X05/form4-02182026_120251.xml 0001231919-26-000164 13323
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-26-000142 005-95351 26632842 34 108498
2026-02-13 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-049888 001-42938 26628955 34 1684509 1 1
2026-02-10 8-K 8-K 7.01,9.01 0001193125-26-043771 001-42938 26613541 34 13373053 1 1
2025-12-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000937 9175
2025-12-19 4 PRIMARY DOCUMENT 0001678620-25-000013 5645
2025-12-11 4 PRIMARY DOCUMENT 0001620548-25-000011 4879
2025-12-11 4 PRIMARY DOCUMENT 0002092017-25-000009 4885
2025-12-11 4 PRIMARY DOCUMENT 0001742496-25-000012 5856
2025-12-11 4 PRIMARY DOCUMENT 0002091053-25-000009 4864
2025-12-11 4 PRIMARY DOCUMENT 0001757072-25-000010 4848
2025-12-11 4 PRIMARY DOCUMENT 0001678620-25-000011 4882
2025-12-11 10-Q 10-Q 0001193125-25-315972 001-42938 251565177 34 11577058 1 1
2025-12-11 8-K 8-K 2.02,9.01 0001193125-25-315918 001-42938 251565026 34 1266953 1 1
2025-11-17 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001346824-25-000063 005-95351 251491593 34 27208
2025-11-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001757283-25-000005 005-95351 251491467 34 15841
2025-11-14 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-283141 005-95351 251487138 34 429252
2025-11-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000730 35827
2025-11-12 4 xslF345X05/form4-11122025_091126.xml 0001346824-25-000049 16100
2025-11-12 4 xslF345X05/form4-11122025_091112.xml 0001876264-25-000006 14099
2025-11-12 4 xslF345X05/form4-11122025_091104.xml 0002094941-25-000004 14119
2025-11-12 4 xslF345X05/form4-11122025_091154.xml 0001620548-25-000009 6938
2025-11-12 4 xslF345X05/form4-11122025_091148.xml 0002092017-25-000007 6937
2025-11-12 4 xslF345X05/form4-11122025_091142.xml 0001742496-25-000010 7954
2025-11-12 4 xslF345X05/form4-11122025_091138.xml 0001551966-25-000007 34910
2025-11-12 4 xslF345X05/form4-11122025_091133.xml 0002091053-25-000007 6916
2025-11-12 4 xslF345X05/form4-11122025_091132.xml 0001347383-25-000009 6883
2025-11-12 4 xslF345X05/form4-11122025_091140.xml 0001757072-25-000008 6899
2025-11-12 4 xslF345X05/form4-11122025_091121.xml 0001678620-25-000009 9379
2025-11-07 S-8 S-8 0001193125-25-272519 333-291386 251463361 33 416304 1 1
2025-11-07 4 xslF345X05/form4-11072025_041114.xml 0001347383-25-000007 5441
2025-11-07 4 xslF345X05/form4-11072025_041112.xml 0001290976-25-000010 5685
2025-11-07 4 xslF345X05/form4-11072025_041110.xml 0001216994-25-000008 5457
2025-11-07 4 xslF345X05/form4-11072025_041109.xml 0002092017-25-000005 5512
2025-11-07 4 xslF345X05/form4-11072025_041107.xml 0002091053-25-000005 5491
2025-11-07 4 xslF345X05/form4-11072025_041105.xml 0001757072-25-000006 5474
2025-11-07 4 xslF345X05/form4-11072025_041102.xml 0001620548-25-000007 5504
2025-11-07 4 xslF345X05/form4-11072025_041104.xml 0001742496-25-000008 5487
2025-11-07 8-K 8-K 5.03,9.01 0001193125-25-272282 001-42938 251462462 34 182138 1 1
2025-11-06 424B4 424B4 0001193125-25-270066 333-290793 251459468 33 11011767
2025-11-06 FWP FWP 0001193125-25-267581 333-290793 251455666 34 11494
2025-11-05 3 xslF345X02/form3-11062025_011125.xml 0001231919-25-000435 13705
2025-11-05 3 xslF345X02/form3-11062025_011108.xml 0001876264-25-000004 8024
2025-11-05 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-25-000705 21705
2025-11-05 3 xslF345X02/form3-11062025_011156.xml 0002094941-25-000002 14265
2025-11-05 3 xslF345X02/form3-11062025_011101.xml 0001620548-25-000005 21006
2025-11-05 3 xslF345X02/form3-11062025_011115.xml 0002092017-25-000003 19073
2025-11-05 3 xslF345X02/form3-11062025_011119.xml 0001742496-25-000006 20805
2025-11-05 3 xslF345X02/form3-11062025_011126.xml 0001216994-25-000006 16197
2025-11-05 3 xslF345X02/form3-11062025_011138.xml 0001290976-25-000008 9453
2025-11-05 3 xslF345X02/form3-11062025_011144.xml 0001551966-25-000005 24716
2025-11-05 3 xslF345X02/form3-11062025_011152.xml 0002091053-25-000003 21348
2025-11-05 3 xslF345X02/form3-11062025_011155.xml 0001792061-25-000003 9291
2025-11-05 3 xslF345X02/form3-11062025_011151.xml 0001347383-25-000005 17111
2025-11-05 3 xslF345X02/form3-11062025_011111.xml 0001757072-25-000004 19047
2025-11-05 3 xslF345X02/form3-11062025_121116.xml 0001678620-25-000007 20450
2025-11-05 CERT NYSE CERTIFICATION 0000876661-25-000841 001-42938 251452010 34 164565
2025-11-04 8-A12B 8-A12B 0001193125-25-264660 001-42938 251448915 34 14606
2025-10-30 FWP FWP 0001193125-25-257360 333-290793 251432094 34 10971
2025-10-17 S-1/A S-1/A 0001193125-25-242492 333-290793 251400868 33 11814381 1 1
2025-10-09 S-1 S-1 0001193125-25-235673 333-290793 251384547 33 15938213 1 1
2025-09-23 DRS/A filename1.htm 0001193125-25-211895 377-08010 251331520 33 11216430
2025-09-22 DRSLTR filename1.htm 0001193125-25-211922 28664
2025-09-10 UPLOAD filename1.pdf 0000000000-25-009825 377-08010 46546
2025-09-02 DRS/A filename1.htm 0000950123-25-008631 377-08010 251282582 33 10290910
2025-08-29 DRSLTR filename1.htm 0000950123-25-008632 40521
2025-07-30 UPLOAD filename1.pdf 0000000000-25-008014 377-08010 48506
2025-07-18 DRSLTR filename1.htm 0000950123-25-006473 65567
2025-07-18 DRS/A filename1.htm 0000950123-25-006472 377-08010 251134954 33 12643239
2025-06-10 UPLOAD filename1.pdf 0000000000-25-006098 377-08010 59089
2025-05-14 DRS filename1.htm 0000950123-25-005244 377-08010 25946312 33 5699584
2025-01-08 D xslFormDX01/primary_doc.xml 06b 0002044725-25-000004 021-534546 25517241 33 15670
2025-01-08 D xslFormDX01/primary_doc.xml 06b 0002044725-25-000003 021-534516 25516204 33 15668
2025-01-08 D xslFormDX01/primary_doc.xml 06b 0002044725-25-000002 021-534510 25516104 33 15675
2025-01-07 D xslFormDX01/primary_doc.xml 06b 0002044725-25-000001 021-534380 25512798 33 15669

Latest XBRL company facts

One latest value per concept from companyfacts (223 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 41.35M 2026-11-10 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-093932
ffd NetFeeAmt NetFeeAmt USD 16,230.26 2026-04-14 S-1 2026-04-17 0001193125-26-161516
ffd TtlFeeAmt TtlFeeAmt USD 16,230.26 2026-04-14 S-1 2026-04-17 0001193125-26-161516
ffd TtlOfferingAmt TtlOfferingAmt USD 117.53M 2026-04-14 S-1 2026-04-17 0001193125-26-161516
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-14 S-1 2026-04-17 0001193125-26-161516
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-14 S-1 2026-04-17 0001193125-26-161516
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment USD 300,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 557.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 1.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 12.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap Assets Assets USD 278.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap AssetsCurrent Assets, Current USD 174.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 47.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 48.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 36.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 36.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 3.00M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 257.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value USD 8.93M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DebtSecuritiesHeldToMaturityFairValueCurrent DebtSecuritiesHeldToMaturityFairValueCurrent USD 120.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap DebtSecuritiesHeldToMaturityFairValueNoncurrent DebtSecuritiesHeldToMaturityFairValueNoncurrent USD 92.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.10M 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 5.63M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 52.81M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 52.39M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 11.97M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 129,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 6.26M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 525,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 52.39M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap DividendsCommonStock Dividends, Common Stock USD 1.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.193 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.033 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances USD 8.93M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) USD 8.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 8.93M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 811,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 469,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 342,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 906,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 433,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 4,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 162,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 95,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 370,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 370,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.09 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 23.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 49.24M 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 393,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 121.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 49.24M 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap HeldToMaturitySecuritiesNoncurrent Debt Securities, Held-to-maturity, Noncurrent USD 93.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -68.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -68.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 13.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -14.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 276,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 837,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 458,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -833,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap InterestReceivable Interest Receivable USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap Investments Investments USD 214.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 213.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LeaseCost Lease, Cost USD 2.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 9.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 394,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 464,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap Liabilities Liabilities USD 26.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 278.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LiabilitiesCurrent Liabilities, Current USD 20.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap LongTermInvestments Long-term Investments USD 93.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 117.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -40.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -73.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -84.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -68.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 652,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-337984
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingExpenses Operating Expenses USD 92.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -92.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 7.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 7.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.089 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 410,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 42,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 469,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 261,000 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 7.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 15.69M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-337984
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.10M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 874,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 173.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 499,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 38.77M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 157.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 117.10M 2026-02-01 2026-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 117.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 46.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 133.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 977,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -84.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RepaymentsOfDebt Repayments of Debt USD 158,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-12-11 0001193125-25-315972
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 68.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RestrictedCash Restricted Cash USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -305.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 652,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 6.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 27.88 2026-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.887 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.816 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211963
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 12.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.19 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 6.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 276,982 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.3 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211963
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 5,503 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 16.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.85 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 16.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 11.85 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 13,552 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.72 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 15.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 25.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShortTermInvestments Short-term Investments USD 121.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 771,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 251.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.117 2025-10-17 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 4.49M 2026-02-01 2026-02-28 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 355,016 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 257.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 117.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 977,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.60M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 75,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 608,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 13.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093932
us-gaap VariableLeaseCost Variable Lease, Cost USD 447,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 35.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 35.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 35.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458385

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →